Viriom's Grant

Viriom raised a round of funding on May 11, 2016. Investors include Skolkovo Foundation.

Viriom is a late stage biotech company developing novel and affordable therapies against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 2/…

Articles about Viriom's Grant: